Tirzepatide for Obstructive Sleep Apnea and Obesity | NEJM

Name: Tirzepatide for Obstructive Sleep Apnea and Obesity | NEJM
Uploaded: 2024-10-03T00:00:00
Description: Tirzepatide reduces sleep apnea severity and body weight in adults with obesity, based on two phase 3 trials. Results show significant improvement in apnea-hypopnea index.

1 min read

Medical Disclaimer: This content is for educational purposes only and is not medical advice. Consult a qualified professional for medical decisions.

Video Info

Duration:0:00

Published:October 3, 2024

Category:tirzepatide

Tirzepatide for Obstructive Sleep Apnea and Obesity | NEJM

Description

Full Transcript

AI-Generated Article

Video Info